Inhibiting a Metabolic Regulator in Specialized Immune Cells Increases Inflammation
Therapeutically inhibiting a metabolic regulator in monocytes unexpectedly increased inflammatory signaling, revealing mechanisms that could inform new strategies to treat chronic inflammatory disorders, according to a recent study.
CRISPR Pioneer Jennifer Doudna Receives Inaugural Kimberly Prize
CRISPR pioneer and Nobel Laureate Jennifer Doudna, PhD is the recipient of the inaugural $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.
Improving Drug Therapy for Relapsed Leukemia
A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.